Sepracor Lunesta Ads Are Top At Brand Recognition, IAG Research Finds
Executive Summary
Sepracor's television ads for its sleep aid Lunesta create brand recognition better than other new prescription drug direct-to-consumer ads, according to an analysis performed by IAG Research
You may also be interested in...
Lunesta ads not lulling people to sleep
Television ads for Sepracor's insomnia agent Lunesta are the top two most recalled new prescription drug ads from the 2006/2007 TV season, according to a survey by IAG Research. Lunesta DTC ads, which feature a luna moth, were most effective at stimulating brand recall last year as well (1"The Pink Sheet" Dec. 4, 2006, p. 12). Pfizer and Schering-Plough's allergy medicines Zyrtec and Nasonex came in third and fourth respectively, and another sleep aid, Takeda's Rozerem, scored fifth highest on the recall index. Three cholesterol-lowering therapies - Pfizer's Lipitor, AstraZeneca's Crestor and Merck/Schering-Plough's Vytorin - tie for sixth...
Lunesta ads not lulling people to sleep
Television ads for Sepracor's insomnia agent Lunesta are the top two most recalled new prescription drug ads from the 2006/2007 TV season, according to a survey by IAG Research. Lunesta DTC ads, which feature a luna moth, were most effective at stimulating brand recall last year as well (1"The Pink Sheet" Dec. 4, 2006, p. 12). Pfizer and Schering-Plough's allergy medicines Zyrtec and Nasonex came in third and fourth respectively, and another sleep aid, Takeda's Rozerem, scored fifth highest on the recall index. Three cholesterol-lowering therapies - Pfizer's Lipitor, AstraZeneca's Crestor and Merck/Schering-Plough's Vytorin - tie for sixth...
Levitra Detailing Message Is “Rapid And Reliable”; Onset Of Action Studied
Bayer and GlaxoSmithKline are positioning Levitra as "rapid" and "reliable" in communications with doctors